Rural–Urban Differences in Provider Types Diagnosing and Prescribing for Patients with Alzheimer's Disease
Author(s)
Park J, Lin H, Wallick CJ
Genentech, Inc., South San Francisco, CA, USA
Presentation Documents
OBJECTIVES:
Although roughly 20% of the US population lives in rural areas, only 9% of US physicians practice in rural communities. Importantly, the lack of access to specialists has been identified as the primary reason for worse health outcomes in rural patients with chronic conditions than their urban counterparts. This study aims to identify and compare the provider types diagnosing and prescribing for patients with Alzheimer’s disease (AD) in rural and urban settings.METHODS:
We conducted a retrospective cohort study in IBM MarketScan® to identify provider types including physician specialties, nurse practitioners, and physician assistants diagnosing and prescribing for patients with AD. Neurologists were classified as AD specialists for analysis. Patients newly diagnosed with AD and AD prescriptions written between 2016 and 2019 were analyzed. Two-sample z-tests were used to compare the proportion of specialists and non-physician providers diagnosing and prescribing for patients with AD in both settings.RESULTS:
In total, 9,964 patients with AD and 103,067 AD prescriptions were included in our analyses. 16.96% of patients were diagnosed and 16.54% of prescriptions were written in rural settings. In rural areas, a significantly lower proportion of prescriptions were written by specialists (95% CI: -0.059, -0.046), while a significantly higher proportion of prescriptions were written by non-physicians (95% CI: 0.020, 0.028). Similarly, a significantly lower proportion of patients in rural settings were diagnosed by specialists (95% CI: -0.054, -0.019). The proportion of patients in rural and urban settings diagnosed by non-physicians did not significantly differ (95% CI: -0.014, 0.011). CONCLUSION: Patients with AD in urban areas are more likely to be diagnosed by or receive prescriptions from AD specialists than patients in rural areas. Care patterns are expected to evolve with disease-modifying treatment approval—thus, proactive and strategic efforts to safeguard access to AD specialists for rural patients will be necessary.Conference/Value in Health Info
2022-05, ISPOR 2022, Washington, DC, USA
Value in Health, Volume 25, Issue 6, S1 (June 2022)
Acceptance Code
P18
Topic
Organizational Practices
Topic Subcategory
Geographic & Regional
Disease
Geriatrics